HOPERMANN HEIMTIERPRODUKTE GMBH – Trademark Portfolio

Entity Type: 99

HOPERMANN HEIMTIERPRODUKTE GMBH holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. The owner is based in 4200 Oberhausen.

Zum Eisenhammer 53

4200 Oberhausen , DE

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MISSY
MISSY
Cancelled 1991
SISSY
SISSY
Cancelled 1991
TOSSY
TOSSY
Cancelled 1991
MAUNZ
MAUNZ
Cancelled 1991

Trademark Classifications

HOPERMANN HEIMTIERPRODUKTE GMBH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

31
Natural Agricultural Products (4 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

Frequently Asked Questions

How many trademarks does HOPERMANN HEIMTIERPRODUKTE GMBH have?

HOPERMANN HEIMTIERPRODUKTE GMBH has 4 U.S. trademarks filed with the USPTO.

What trademark classes does HOPERMANN HEIMTIERPRODUKTE GMBH file in?

HOPERMANN HEIMTIERPRODUKTE GMBH files trademarks across 3 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals), Class 18 (Leather Goods). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.

What is HOPERMANN HEIMTIERPRODUKTE GMBH's trademark registration success rate?

HOPERMANN HEIMTIERPRODUKTE GMBH has a 0% trademark registration rate, with 0 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.